Autoimmune diseases (AID) are increasingly prevalent conditions which comprise more
than 100 distinct clinical entities that are responsible for a great disease burden worldwide …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
arterial and venous thrombotic manifestations and/or pregnancy-related complications in …

Objective. To develop and validate a risk score [global APS score (GAPSS)] derived from the
combination of independent risk for thrombosis and pregnancy loss (PL), taking into account …

Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …

Infertility consists by definition in” failure to achieve a clinical pregnancy after 12 months or
more of regular unprotected intercourse” while the term subfertility means a delay to achieve …

Standardized enzyme-linked immunosorbent assays (ELISAs) for anticardiolipin (aCL) and
anti–2-glycoprotein I (anti-2GPI), though required for diagnosis of the antiphospholipid …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

Background: The aim of the study was to determine the prevalence and clinical associations
of antiphosphatidylserine/prothrombin antibodies (aPS/PT) with thrombosis and pregnancy …

The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular
thrombosis or miscarriages but includes additional manifestations that cannot be explained …